4//SEC Filing
Newman Michael James 4
Accession 0001493152-22-003002
CIK 0001857044other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:08 PM ET
Size
7.3 KB
Accession
0001493152-22-003002
Insider Transaction Report
Form 4
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
- Sale
Common Stock
2022-01-31$5.00/sh−5,870$29,351→ 1,382,486 total(indirect: See footnote) - Sale
Common Stock
2022-02-01$5.00/sh−14,130$70,692→ 1,368,356 total(indirect: See footnote)
Footnotes (3)
- [F1]The sale of shares of common stock reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2021.
- [F2]Consists of (i) 1,355,654 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.
- [F3]Consists of (i) 1,341,524 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001876315
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:08 PM ET
- Size
- 7.3 KB